O'Reilly R A
Am J Med Sci. 1979 Mar-Apr;277(2):189-94.
To evaluate the effect of mealtime wine of the hypoprothrombinemic effect of anticoagulant therapy, eight normal subjects were anticoagulated at therapeutic levels for 21 days. Eight experiments were performed with racemic warfarin alone, 7 with warfarin plus a total of 10 oz mealtime wine per day ingested, and 6 with warfarin plus a total of 20 oz wine per day. Each subject served as his own control. After day 3, the average one-stage prothrombin activity was 33%, 33%, and 32% and the average warfarin level was 2.9, 2.9, and 3.1 microgram/ml for warfarin alone, warfarin plus 10 oz of wine, and warfarin plus 20 oz of wine, respectively. It is concluded that 10 and even 20 oz of daily mealtime wine has no effect on therapeutic hypoprothrombinemia.
为评估进餐时饮酒对抗凝治疗所致低凝血酶原血症的影响,8名正常受试者接受了为期21天的治疗水平抗凝治疗。单独使用消旋华法林进行了8次实验,7次实验中受试者在服用华法林的同时每天摄入总量为10盎司的进餐时饮用的葡萄酒,6次实验中受试者在服用华法林的同时每天摄入总量为20盎司的葡萄酒。每名受试者均作为自身对照。第3天后,单独使用华法林、华法林加10盎司葡萄酒、华法林加20盎司葡萄酒时,平均一期凝血酶原活性分别为33%、33%和32%,平均华法林水平分别为2.9、2.9和3.1微克/毫升。结论是,每天进餐时饮用10盎司甚至20盎司葡萄酒对治疗性低凝血酶原血症无影响。